1Flageole H, Raptis S, Trudel JL,Lough JO. Progression toward malignancy of hamartomas, in apatient with Peutz-Jegherssyndrome: case reportand literature review. Can J Surg, 1994, 37: 231～236.
2Avizienyte E, Roth S, Loukola A, Hemmiki A,Lothe RA, Stenwig AE, Foss SD, SalovaaraR,Aaltonen LA. Somatic mutations in LKB1 arerare in sporadic colorectal and testiculartumors.Cancer Res, 1998, 58: 2087～2090.
3Mehenni H, Gehrig C, Nezu J, Oku A, ShimaneM, Rossier C, Guex N, Blouin JL, ScottHS, Antonarakis SE. Loss of LKB1 kinase activity in PeutzJeghers syndrome, and evidencefor allelic andlocus heterogeneity. Am J Hum Genet, 1998, 63:1641～ 1650.
4Trojan J, Brieger A, Raedle J, Roth WK, ZeuzemS. Peutz-Jeghers syndrome: molecularanalysis ofa three-generation kindred with a novel defect inthe serine threonine kinasegene STK11. Am JGastroenterol, 1999, 94: 257～261.
5Rowan A, Bataille V, MacKie R, Healy E, Bick-nell D, Bodmer W, Tomlinson I. Somaticmuta-tions in the Peutz-Jeghers (LKB1/STK11) gene insporadic malignant melanomas. J InvestDerma-tol, 1999, 112: 509～511.
6Gruber SB, Entius MM, Petersen GM, Laken SJ,Longo PA, Boyer R, Levin AM, MujumdarUJ,Trent JM, Kinzler KW, Vogelstein B, HamiltonSR, Polymeropoulos MH, Offerhaus GJ,GiardielloFM. Pathogenesis of adenocarcinoma in Peutz-Jeghers syndrome. Cancer Res, 1998,58: 5267～5270.
